199 related articles for article (PubMed ID: 16247464)
1. Downregulation of E-cadherin by hepatitis B virus X antigen in hepatocellullar carcinoma.
Liu J; Lian Z; Han S; Waye MM; Wang H; Wu MC; Wu K; Ding J; Arbuthnot P; Kew M; Fan D; Feitelson MA
Oncogene; 2006 Feb; 25(7):1008-17. PubMed ID: 16247464
[TBL] [Abstract][Full Text] [Related]
2. Altered expression of E-cadherin in hepatocellular carcinoma: correlations with genetic alterations, beta-catenin expression, and clinical features.
Wei Y; Van Nhieu JT; Prigent S; Srivatanakul P; Tiollais P; Buendia MA
Hepatology; 2002 Sep; 36(3):692-701. PubMed ID: 12198663
[TBL] [Abstract][Full Text] [Related]
3. Cadherin/catenin complex appears to be intact in hepatocellular carcinomas from Australia and South Africa.
Herath NI; Walsh MD; Kew MC; Young J; Leggett BA; Macdonald GA
J Gastroenterol Hepatol; 2004 Jun; 19(6):676-82. PubMed ID: 15151624
[TBL] [Abstract][Full Text] [Related]
4. [Expression patterns of E-cadherin and beta-catenin according to clinicopathological characteristics of hepatocellular carcinoma].
Bae SH; Jung ES; Park YM; Jang JW; Choi JY; Cho SH; Yoon SK; Ahn BM; Cha SB; Chung KW; Sun HS; Park DH; Kim BK; Kim DG
Taehan Kan Hakhoe Chi; 2002 Sep; 8(3):297-303. PubMed ID: 12499787
[TBL] [Abstract][Full Text] [Related]
5. Association of E-cadherin and beta-catenin with metastasis in nasopharyngeal carcinoma.
Li Z; Ren Y; Lin SX; Liang YJ; Liang HZ
Chin Med J (Engl); 2004 Aug; 117(8):1232-9. PubMed ID: 15361301
[TBL] [Abstract][Full Text] [Related]
6. Hepatitis B x antigen up-regulates vascular endothelial growth factor receptor 3 in hepatocarcinogenesis.
Lian Z; Liu J; Wu M; Wang HY; Arbuthnot P; Kew M; Feitelson MA
Hepatology; 2007 Jun; 45(6):1390-9. PubMed ID: 17539024
[TBL] [Abstract][Full Text] [Related]
7. Beta-catenin accumulation in the progression of human hepatocarcinogenesis correlates with loss of E-cadherin and accumulation of p53, but not with expression of conventional WNT-1 target genes.
Prange W; Breuhahn K; Fischer F; Zilkens C; Pietsch T; Petmecky K; Eilers R; Dienes HP; Schirmacher P
J Pathol; 2003 Oct; 201(2):250-9. PubMed ID: 14517842
[TBL] [Abstract][Full Text] [Related]
8. Hepatitis B x antigen in hepatitis B virus carrier patients with liver cancer.
Wang WL; London WT; Feitelson MA
Cancer Res; 1991 Sep; 51(18):4971-7. PubMed ID: 1654208
[TBL] [Abstract][Full Text] [Related]
9. Up-regulation of human cervical cancer proto-oncogene contributes to hepatitis B virus-induced malignant transformation of hepatocyte by down-regulating E-cadherin.
Li J; Dai X; Zhang H; Zhang W; Sun S; Gao T; Kou Z; Yu H; Guo Y; Du L; Jiang S; Zhang J; Zhou Y
Oncotarget; 2015 Oct; 6(30):29196-208. PubMed ID: 26470691
[TBL] [Abstract][Full Text] [Related]
10. Wnt-1 protein as a prognostic biomarker for hepatitis B-related and hepatitis C-related hepatocellular carcinoma after surgery.
Lee HH; Uen YH; Tian YF; Sun CS; Sheu MJ; Kuo HT; Koay LB; Lin CY; Tzeng CC; Cheng CJ; Tang LY; Tsai SL; Wang AH
Cancer Epidemiol Biomarkers Prev; 2009 May; 18(5):1562-9. PubMed ID: 19423534
[TBL] [Abstract][Full Text] [Related]
11. Relation among p130Cas, E-cadherin and beta-catenin expression, clinicopathologic significance and prognosis in human hepatocellular carcinoma.
Guo C; Liu QG; Yang W; Zhang ZL; Yao YM
Hepatobiliary Pancreat Dis Int; 2008 Oct; 7(5):490-6. PubMed ID: 18842495
[TBL] [Abstract][Full Text] [Related]
12. Epigenetic changes induced by reactive oxygen species in hepatocellular carcinoma: methylation of the E-cadherin promoter.
Lim SO; Gu JM; Kim MS; Kim HS; Park YN; Park CK; Cho JW; Park YM; Jung G
Gastroenterology; 2008 Dec; 135(6):2128-40, 2140.e1-8. PubMed ID: 18801366
[TBL] [Abstract][Full Text] [Related]
13. [Chronic hepatitis B virus infection and the methylation status of p16INK4A promoter].
Zhu R; Li BZ; Ling YQ; Zhang HP; Li H; Liu Y; Hu XQ; Zhu HG
Zhonghua Zhong Liu Za Zhi; 2007 Mar; 29(3):166-70. PubMed ID: 17649629
[TBL] [Abstract][Full Text] [Related]
14. Liver-intestine cadherin predicts microvascular invasion and poor prognosis of hepatitis B virus-positive hepatocellular carcinoma.
Ding ZB; Shi YH; Zhou J; Shi GM; Ke AW; Qiu SJ; Wang XY; Dai Z; Xu Y; Fan J
Cancer; 2009 Oct; 115(20):4753-65. PubMed ID: 19626651
[TBL] [Abstract][Full Text] [Related]
15. E-cadherin suppression accelerates squamous cell carcinoma progression in three-dimensional, human tissue constructs.
Margulis A; Zhang W; Alt-Holland A; Crawford HC; Fusenig NE; Garlick JA
Cancer Res; 2005 Mar; 65(5):1783-91. PubMed ID: 15753375
[TBL] [Abstract][Full Text] [Related]
16. Association of p16INK4A hypermethylation with hepatitis B virus X protein expression in the early stage of HBV-associated hepatocarcinogenesis.
Zhu R; Li BZ; Li H; Ling YQ; Hu XQ; Zhai WR; Zhu HG
Pathol Int; 2007 Jun; 57(6):328-36. PubMed ID: 17539963
[TBL] [Abstract][Full Text] [Related]
17. Macrophage activation increases the invasive properties of hepatoma cells by destabilization of the adherens junction.
Lin CY; Lin CJ; Chen KH; Wu JC; Huang SH; Wang SM
FEBS Lett; 2006 May; 580(13):3042-50. PubMed ID: 16678166
[TBL] [Abstract][Full Text] [Related]
18. Hepatitis B virus X protein overcomes the growth-inhibitory potential of retinoic acid by downregulating retinoic acid receptor-beta2 expression via DNA methylation.
Jung JK; Park SH; Jang KL
J Gen Virol; 2010 Feb; 91(Pt 2):493-500. PubMed ID: 19828754
[TBL] [Abstract][Full Text] [Related]
19. Hepatitis B virus X protein represses E-cadherin expression via activation of DNA methyltransferase 1.
Lee JO; Kwun HJ; Jung JK; Choi KH; Min DS; Jang KL
Oncogene; 2005 Oct; 24(44):6617-25. PubMed ID: 16007161
[TBL] [Abstract][Full Text] [Related]
20. Invasion and metastasis of oral cancer cells require methylation of E-cadherin and/or degradation of membranous beta-catenin.
Kudo Y; Kitajima S; Ogawa I; Hiraoka M; Sargolzaei S; Keikhaee MR; Sato S; Miyauchi M; Takata T
Clin Cancer Res; 2004 Aug; 10(16):5455-63. PubMed ID: 15328184
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]